People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs
Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound
Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
Young woman stays undetectable for twelve years off treatment after early HIV therapy
Starting HIV treatment early and then interrupting is no better than delaying it
The 'Boston patients' experience HIV rebound after stem cell transplants
